Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

NCT05509543 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Pharmacokinetics

Interventions

DRUG: IY-NT-T
DRUG: IY-NT-R

Sponsor

Il-Yang Pharm. Co., Ltd.